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Abstract
Preliminary evidence indicates that dopamine given by mouth facilitates the learning of motor skills and improves the
recovery of movement after stroke. The mechanism of these phenomena is unknown. Here, we describe a mechanism by
demonstrating in rat that dopaminergic terminals and receptors in primary motor cortex (M1) enable motor skill learning
and enhance M1 synaptic plasticity. Elimination of dopaminergic terminals in M1 specifically impaired motor skill
acquisition, which was restored upon DA substitution. Execution of a previously acquired skill was unaffected. Reversible
blockade of M1 D1 and D2 receptors temporarily impaired skill acquisition but not execution, and reduced long-term
potentiation (LTP) within M1, a form of synaptic plasticity critically involved in skill learning. These findings identify a
behavioral and functional role of dopaminergic signaling in M1. DA in M1 optimizes the learning of a novel motor skill.
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Introduction
Levodopa, a stable precursor of dopamine (DA), improves the
recovery of movement abilities in disabled stroke survivors when
given by mouth before daily physiotherapy sessions [1]. Plastic
adaptations in the brain are partly responsible for such recovery
processes [2,3] as well as for learning of a motor skill [4].
Levodopa improves such adaptations in stroke [5] and healthy
subjects [6], and its metabolite levels correlate with the
effectiveness of skill learning [7]. Finally, skill learning is impaired
in patients with Parkinson’s disease in whom the brain’s
dopaminergic system degenerates [8]. The mechanisms for all
these phenomena are unknown.
Here, we present findings suggesting that these phenomena are
explained by dopaminergic transmission in primary motor cortex
(M1) that enables M1 synaptic plasticity.
Midbrain dopaminergic neurons project diffusely to many
cortical regions, among those to primary motor cortex [9].
Dopaminergic terminals have been demonstrated in superficial
and deep layers of the rodent and primate M1 [9,10]. DA
receptors of the D1 and D2 subtype are present in M1 in these
species [11,12,13] as well as in humans [14]. The functional role of
this projection for behavior is unknown.
In prefrontal cortex (PFC) and striatum DA is involved in the
expression of synaptic plasticity by modulating the amount of long-
term potentiation (LTP) and depression (LTD) of glutamatergic
synapses [15,16,17,18,19]. LTP and LTD are the best character-
ized candidate mechanisms underlying learning and memory
[20,21]. In M1, neurons are capable of expressing LTP and LTD
[22]. Learning a new motor skill exhausts the capacity of M1
neurons to express LTP [23] suggesting that M1-LTP is a cellular
mechanism enabling motor skill learning [24,25,26].
We therefore hypothesized that dopaminergic neurotransmis-
sion in M1 supports motor skill learning by modulating M1
synaptic plasticity. We show that pre- and postsynaptic interfer-
ence with dopaminergic neurotransmission in M1 impairs motor
skill learning and M1 synaptic plasticity.
Results
Dopamine terminals in M1 and motor skill learning
Motor skill learning was impaired in rats with destroyed M1
dopaminergic terminals in the forelimb area of the primary motor
cortex (M1). Dopaminergic terminals were selectively eliminated by
intracortical injection of 6-hydroxydopamine (6-OHDA) into the
M1 forelimb area of the hemisphere contralateral to the preferred
forelimb in conjunction with desipramine (i.p.) to protect norad-
renergic terminals (6-OHDA+D, n=6). The location of the
forelimb area was determined by stimulation mapping. Learning
curves were compared to sham-lesioned rats (vehicle, n=11) and to
rats with selectively destroyed M1 noradrenergic terminals by
intracortical injection of 6-OHDA into the M1 forelimb area in
conjunction with nomifensine (i.p.) to protect dopaminergic
terminals (6-OHDA+N, n=6). The acquisition of a skilled forelimb
reaching task was significantly impaired in 6-OHDA+D but not in
6-OHDA+N animals compared to vehicle (Figure 1a, group6time
interaction: F(12,114)=3.66; p,0.001, power 1.00; Bonferroni-
corrected post hoc test between 6-OHDA+D and vehicle, p,0.001,
power 1.00, and between 6-OHDA+D and 6-OHDA+N animals,
p=0.045, power 0.94). The slight reduction in reaching perfor-
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significant but the sample size was too small to conclusively evaluate
the effect (p=0.315). The time interval between reaching trials
(pellet removal to subsequent door opening) was not different
between groups (time6group interaction: p=0.09, power 0.82)
suggesting that the motivation was not affected by elimination of
M1 dopaminergic terminals. Destroying M1 dopaminergic termi-
nals at a time when the reaching task was already acquired had no
effect on task performance (Figure 1b, n=10, difference between
day 11 and days 12-15, p=0.87) indicating that dopamine is
necessary for skill acquisition but not for movement execution.
DA substitution using its precursor levodopa injected into the
M1 forelimb representation reversed the 6-OHDA+D induced
learning impairment. 6-OHDA+D and sham-lesioned rats were
first trained for 6 days reproducing the findings described above in
a new set of animals (Figure 1c, phase 1, interaction group6time:
F(10,100)=3.14, p=0.002, power 0.98, post-hoc difference 6-
OHDA+D+DA, n=7, vs. vehicle+DA, n=10: p,0.001, power
0.96, 6-OHDA+D+vehicle, n=7, vs.vehicle+DA: p=0.007, power
0.85, 6-OHDA+D+DA vs. 6-OHDA+D+vehicle: p=1.00). Rats
were then trained for six additional days after implantation of
osmotic minipumps delivering either levodopa or vehicle into the
Figure 1. Dopamine (DA) release in M1 is necessary for optimal motor skill acquisition but not for movement execution. (a) Learning
curves for sham-lesioned rats (black, vehicle), rats with dopaminergic terminals destroyed (red, 6-OHDA+D), and rats with noradrenergic terminals
destroyed (blue, 6-OHDA+N). Cortical injections (vertical arrows) were performed following an initial training session to determine paw preference.
After 3 days of recovery from surgery (horizontal arrow, necessary interval determined in d) rats were trained for 6 successive days. The success rate
of skill acquisition was significantly impaired in animals with without dopaminergic terminals but not in animals without noradrenergic terminals
(** p,0.05). (b) DA is not required for task performance because elimination of dopaminergic terminals in M1 (red, vertical arrow) in rats that already
acquired the reaching skill (black) did not affect reaching performance. (c) Learning impairment is restored with DA substitution (administration of its
precursor levodopa). Rats received cortical injections of 6-OHDA+D and were trained comparable to a): As compared with sham-lesioned animals
(vehicle-injected, black), the two groups without dopaminergic terminals in M1 (6-OHDA+D-injected, red) demonstrated a learning impairment –
phase 1. Rats were then implanted with minipumps (drops): 50% of DA terminal deficient rats received vehicle (grey) and 50% received levodopa
(yellow) during the entire second training period, sham-lesioned rats received levodopa – phase 2. Learning was restored in DA-substituted rats
underlining the importance of DA for skill acquisition. Minipumps were then removed and all rats were examined for task recall after 6 days of rest.
DA is not required to recall an already learned skill as indicated by unchanged performance levels in all groups. (d) Cortical injections independent of
whether 6-OHDA or vehicle was used transiently impair locomotor function. Rotarod tests were performed in vehicle- (black) and 6-OHDA (red)
injected rats. Parallel deficits indicate that reduced rotarod speed results from injection or surgery and not from the drug itself. Results were usedt o
determine the recovery period following surgery (horizontal arrows in a-c).
doi:10.1371/journal.pone.0007082.g001
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treated rats reached control performance within 3 to 4 days while
vehicle-treated rats did not show any performance improvement
(interaction group6time: F(10,105)=2.24, p=0.021, power 0.90,
post-hoc difference 6-OHDA+D+vehicle vs. vehicle+DA: p=0.024,
power 0.79, 6-OHDA+D+DA vs. vehicle+DA: p=1.00, 6-OH-
DA+D+DA vs. 6-OHDA+D+vehicle: p=0.13). Successful recall of
the skill 6 days later did not require levodopa (Figure 2c, phase 3,
differences, t-tests Bonferroni-corrected for 3 comparisons, 6-
OHDA+D+DA vs. 6-OHDA+D+vehicle: p=0.049, power 0.72;
vehicle+DA vs. 6-OHDA+D+DA: p=0.46; vehicle+DA vs. 6-
OHDA+D+vehicle: p=0.11). 6-OHDA+D followed by levodopa
treatment did not affect the animals’ motivation and attention
because the intervals between reaching trials were not different
between groups (p=0.55). They rather slowly decreased during the
three phases of the experiment in all animals (effect of time:
F(5,68)=10.62, p,0.001, power 1.00) [27].
The surgical procedure to perform intracortical injections
caused a transient impairment of motor function as assessed using
an accelerated rotarod test. The deficit between sham-lesioned
(vehicle, n=4) and 6-OHDA-treated rats (n=4) was not different
(Figure 1d, group6time interaction: p=0.61) suggesting that the
impairment of motor function resulted from the surgical procedure
and not from the drug itself. Rotarod performance was lower at
3 hr, 6 hr and 9 hr post-injection (post hoc tests: p,0.05, power
.0.75) with a statistical trend of reduced performance at 24 hr
(p=0.069) as compared with baseline. Performance recovered to
pre-injection levels within 48 hr (Figure 1d, post-hoc difference
to baseline: p=1.00; overall effect of time F(6,30)=3.44, p=0.011,
power 0.88). To guarantee full recovery a 3-day post-injection
period was allowed following surgery before training was
continued.
Successful destruction of dopaminergic terminals in M1 by 6-
OHDA+D injections was verified by immunostaining and western
blot analysis for tyroxin hydroxylase (TH). TH expression was
significantly reduced in the 6-OHDA-treated hemisphere (n=4, 6-
OHDA+D, 0.50160.04) compared with the contralateral hemi-
sphere (0.7660.12, p=0.049, power 0.75, Figure 2a, 2b).
Immunofluorescence was nearly absent in layer I and II/III and
reduced in deeper layers following DA terminal destruction
(Figure 2c). In contrast, TH immunoreactivity after injection of
6-OHDA+N to eliminate noradrenergic terminals was not
significantly reduced (n=4, 0.5460.08) as compared to the non-
injected hemisphere (0.6260.20, p=0.35).
Dopamine receptors in M1 and motor skill learning
The type of DA receptor involved in motor skill learning was
determined by application of specific antagonists. D2 receptors
were temporarily blocked by injection of raclopride or sulpiride,
and D1 receptors by injection of SCH23390 into the M1 forelimb
area contralateral to the forelimb used for reaching. The success
rate was significantly reduced in the presence of raclopride (n=7),
sulpiride (n=6), and SCH23390 (n=6) compared to vehicle-
injected animals (n=8) (Figure 3a, time6group interaction:
F(11,99)=2.54, p=0.001, power 1.00, post-hoc Dunnett’s tests
for comparisons with the control group: raclopride p=0.033,
power 0.86, sulpiride p=0.012, power 0.73, SCH23390
p=0.040, power 0.72). Reaching performance increased upon
discontinuation of the antagonists and reached the level of controls
within three days. Similar to animals in which dopaminergic
Figure 2. Identification of dopaminergic terminals in M1. (a) Western blot analysis of M1 cortical tissue injected with vehicle (sham-lesioned)
and 6-OHDA in conjunction with desipramine (i.p.) using tyroxine hydroxylase (TH) reactivity indicated reduced TH expression after elimination of
dopaminergic terminals. (b) Quantification of protein expression in DA-lesioned (6-OHDA+D) and sham-lesioned hemispheres reveals reduced
protein expression after elimination of dopaminergic terminals. (c) Immunofluorescence staining of cortical dopaminergic terminals (TH
immunoreactivity) in an exemplary vehicle and DA-lesioned hemisphere (6-OHDA injections into M1) indicated almost no staining in layer I and II/III
and reduced staining in deeper layers in the lesioned M1. Similar findings were obtained in the other two animals treated analogously.
doi:10.1371/journal.pone.0007082.g002
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not affected by D1 or D2 antagonists (group6time effect on intertrial
intervals: p=0.98). Raclopride did not alter the execution of the
previously acquired skill (Figure 3b, n=5, effect of time:
F(14,42)=16.97, p,0.001, power 1.00; post-hoc testing: no
significant difference between session 10 and the average of
sessions 11-15, p=0.41). These results suggest the involvement of
D1 and D2 receptors in motor skill acquisition.
Antagonist effects on skill learning were not indirectly caused by
a spread of the drug to neighboring brain regions known to receive
dopaminergic input. Raclopride injected into the dorsal striatum
(n=10, Figure 3c) and the prefrontal cortex (PFC, n=6, 3d)
during motor skill training did not significantly affect learning
curves as compared to vehicle (n=10 for striatum, n=6 for PFC;
interaction group6time: striatum F(7,98)=0.57, p=0.78; PFC
F(7,63)=1.12, p=0.36).
Synaptic transmission and plasticity
Previous studies have shown that motor skill learning enhances
synaptic strength and partially occludes long term potentiation
(LTP) in layer II/III and layer I of the M1 forelimb area [24,25]
suggesting that LTP strengthens synapses during motor skill
learning. Since blocking dopaminergic transmission in M1 during
skill acquisition impairs learning we hypothesized that the learning
impairment might be accompanied by an impairment of LTP.
Therefore, we examined synaptic transmission and synaptic
plasticity in cortical slices before and after DA antagonist
application. Amplitudes of extracellular field potentials (FP) in
Figure 3. Functional D1 and D2 receptors in M1 are necessary for optimal motor skill acquisition but not for movement execution.
(a) Blocking D1 receptors with SCH02339 (green) and D2 receptors with raclopride (blue) or sulpiride (orange) on the second and third day (arrows) of
motor skill training significantly impaired reaching success compared to vehicle injected animals (black). When antagonists were discontinued,
success rate began to increase normally. No significant differences in success rate existed at day 8 between all 4 groups. Inset: exemplary Nissl staint o
verify cannula placement. (b) Raclopride injected into M1 (arrows) after the task had been acquired did not affect the performance. Inset: exemplary
Nissl stain to verify injection cannula placement. (c,d) To exclude the possibility that the antagonists spread to other brain regions receiving
important DA projections thereby causing the observed learning impairment, raclopride was injected into the dorsal striatum (c, blue) and the
prefrontal cortex (d, blue) and compared to vehicle injected controls (black). Skill acquisition was not impaired in these animals. Insets: exemplary
Nissl stain to verify cannula placement.
doi:10.1371/journal.pone.0007082.g003
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antagonist raclopride (Figure 4a, c, 0.81460.050 mV vs.
vehicle: 0.81860.048 mV, n=10, p=0.954) or D1-receptor
antagonist SCH23390 (Figure 4b, c 0.82260.054 mV vs.
vehicle: 0.82760.056 mV, n=22, p=0.952). However, the
capacity for synaptic plasticity was reduced when D1 or D2
receptors were blocked. After establishing baseline responses, LTP
was induced repeatedly until saturated. LTP was significantly
reduced in the presence of raclopride or SCH23390 (raclopride:
110.9961.67%, n=12, SCH23390: 111.9163.99%, n=10) com-
pared to control conditions (142.7465.2%, n=8; effect of group:
F(2,27)=23.6, p,0.001, power 1.00; Bonferroni-corrected post-
hoc difference: raclopride vs- vehicle: p,0.001, power 1.00, SCH
23390 vs. vehicle: p,0.001, power 1.00, raclopride vs. SCH 23390:
p=1.00, power 0.05, Figure 4d-f). With DA receptors blocked
responses were already saturated with a single LTP attempt
Figure 4. Synaptic plasticity but not synaptic transmission depends on DA receptor activity in M1. (a,b) Exemplary time courses of peak
amplitudes of extracellular field potentials (FP) in layer II/III horizontal connections in the M1 forelimb area recorded in brain slices. FP amplitudes at
baseline stimulation intensity before (control) and after D1 (a, SCH02339, green) and D1 receptor blockade (b, raclopride, yellow). Antagonists do not
modify amplitude or shape of FPs. Insets: each trace represents an average of 10 individual traces at times indicated by numbers. (c) Group data
indicate no significant difference before (control) and after antagonist application. (d, e) LTP was induced repeatedly (multiple arrows) until
responses were saturated in normal ACSF (control, grey) and in the presence of SCH02339 (d, green) or raclopride (e, yellow). (f) Group data show
significantly reduced LTP in the presence of D1 and D2 receptor antagonists compared to controls (grey) for single LTP induction (left) and saturated
LTP (right). In the presence of DA antagonists responses are already saturated after the first LTP attempt.
doi:10.1371/journal.pone.0007082.g004
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n=11) while 2 to 4 attempts were required in control condition
(vehicle: 130.2562.93%, n=13, Figure 4f). These results show
that dopaminergic transmission is necessary for optimal expression
of LTP.
Discussion
We found that dopaminergic signaling in primary motor cortex
(M1) is necessary for normal motor skill learning and synaptic
plasticity within M1, but not for the execution of a learned task or
for synaptic transmission.
Neither destruction of M1 dopaminergic terminals nor
dopamine receptor antagonists abolished learning completely.
DA in M1, therefore, seems to act as a modulator of motor skill
learning that enables optimal task acquisition. Other modulators,
such as acetylcholine [28,29], serotonin [30] and GABA [31], may
be able to partially compensate for the lack of DA by increasing (or
decreasing in the case of GABA) their activity restoring some but
not optimal learning.
Recall and execution of the learned movements were intact in
the absence of dopaminergic signaling suggesting that recall and
use of stored motor information does not require DA in M1. This
result does not contradict the well-known influence of central
nervous system DA on movement execution. DA affects behavior
depending on the brain region where it is released. For example,
injections of 6-OHDA into the basal ganglia produce marked
alterations in reaching movements in rats [32]. Our results reveal
no such effects after interfering with dopaminergic transmission in
M1. Instead, we show that DA in M1 is specifically important for
the formation of new motor memories.
M1 is one of the brain regions critically important for motor skill
learning. Eliminating protein synthesis in M1 abolishes the
learning of reaching skills in rats [33]. Asanuma and colleagues
showed that LTP can be induced in M1 by tetanic stimulation of
the somatosensory cortex or by associative stimulation of
somatosensory cortex and thalamus [34]. Considering that motor
learning is impaired after lesioning relevant regions of somato-
sensory cortex [35,36], it is assumed that skill learning is in part
mediated by synaptic plasticity in M1 that is driven by
somatosensory input [37]. Motor skill learning also enhances
synaptic responses of intracortical connections in M1 [23],
occludes LTP in these connections [24] and induces structural
modification of M1 dendritic spines [25]. Here, we show in brain
slices that blocking DA receptors reduces the capacity of
horizontal M1 connections to express LTP. This finding cannot
be explained by a remote dopaminergic effect but is rather the
result of directly blocking DA receptors in M1, because in the slice,
remote inputs from other brain regions, such as the basal ganglia,
are transected. LTP in M1 horizontal connections has been linked
to learning of a skilled reaching task [24] and may therefore be one
mechanism by which DA modulates motor skill learning. In
prefrontal cortex (PFC) DA antagonists similarly reduce LTP [16]
and impair learning and memory [38,39]. Our results emphasize
the role of DA as an essential neurotransmitter involved in cortical
plasticity and learning.
D1 and D2 receptors are generally known to have opposing
effects in individual neurons by increasing and decreasing cAMP
production, respectively [39]. We found that D1 and D2 receptor
antagonists in M1 had similar effects on learning and synaptic
plasticity. They both impair motor skill learning and LTP
formation. These findings seem contradictory to the opposing
intracellular effects of D1 and D2 receptors. Concordant actions of
both antagonists in M1 have been described before. Spontaneous
firing of M1 pyramidal neurons is increased by both D1 and D2
receptor antagonists [40]. Concordant actions could be explained
by a network effect assuming that D1 and D2 receptors – with
opposing intracellular actions – are located on excitatory and
inhibitory neurons leading to a common net effect on M1 output.
In support of this hypothesis, D1 and D2 receptors have been
found to be distributed differently across the layers of M1 [41].
Alternatively, the receptors may exist in alternative configurations
not linked to cAMP production. A dimeric configuration of both
receptors activating phospholipase C has been reported [42].
Phospholipase C increases intracellular Ca
2+ [43] a potent
stimulant for learning and memory [44].
Several methodological issues warrant a critical discussion.
Spread or diffusion of drugs injected into M1 could have resulted
in dopamine depletion or blockade in other brain regions thereby
confounding the behavioral observations. In a previous study we
have evaluated our injection technique and have found no
evidence for spread or diffusion outside of M1 [33]. Here, we
injected raclopride into striatum and PFC, two regions receiving
dense dopaminergic projections, and found no evidence for a
motor learning impairment. This does not contradict the
involvement of striatum and PFC in motor learning due to their
roles in motor control and attention, respectively. It shows that
using identical injections at identical time points for all three
regions, learning is only impaired after motor cortex injections.
Because the effect of a direct injection should be more prominent
than indirect spread or diffusion, false positive results of motor
cortex injections are highly unlikely.
Also intertrial latencies remained unaffected in all our
experiments strengthening the argument for the specificity of
M1-dopaminergic influence on motor skill learning. Latencies
would increase if animals were distracted, not motivated or failed
to remember the spatial and conceptual requirements of the task
(how to open the door, where to find the pellet).
Given previous reports of learning deficits after DA depletion in
striatum [32], it seems unexpected that raclopride injected into
striatum had no effect on learning. However, we have used much
lower concentrations and smaller injection volumes most likely
leading to less spread of drug, hence, affecting less striatal tissue
and different parts of the striatum. Interfering with motor behavior
requires striatal dopamine depletion to pass a certain threshold as
demonstrated by assessing forelimb use symmetry after different
doses of 6-OHDA injected into the striatum [45]. Such a threshold
most likely exists also for the tissue volume affected: Miklyaeva et
al. [32] observed learning impairments after injecting 8 mg6 -
OHDA dissolved in 4 ml. Injections restricted to the medial
striatum had less effect on reaching than those to the lateral
striatum [46]. We injected only 0.5 ml of a raclopride solution
affecting smaller volumes of tissue. Injection volume was chosen to
be identical to cortical injections with the purpose to exclude the
possibility that learning deficits are indirectly caused by raclopride
spreading or diffusing into adjacent brain regions where dopamine
acts as a neurotransmitter.
Our findings offer a mechanism to explain observations that
were previously not understood. In humans learning a motor skill,
measurements of DA metabolites in the cerebrospinal fluid
correlate with the learning rate [7]. Motor skill learning and
plastic adaptation in the M1 is improved by systemic administra-
tion of levodopa [6]. Our finding that M1 dopaminergic signaling
is important for motor skill learning and synaptic plasticity could
explain accelerated movement recovery after brain injury when
motor training is combined with systemic levodopa administration
[1]; plasticity in M1 is a candidate mechanism to support
movement recovery after brain injury [2,47] and this plasticity
Dopamine in Motor Cortex
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dopaminergic neurons degenerate in the substantia nigra (SN) and
the ventral tegmental area (VTA) [48]. It is well known that loss of
dopaminergic neurons projecting from the SN to the striatum
causes the cardinal symptoms of akinesia, tremor and rigidity.
Dopaminergic projections from the SN to cortex have not been
reported [49,50]. However, the VTA contains dopaminergic
neurons projecting to frontal cortex and some evidence exists that
some VTA neurons send axons to M1 [reviewed in 51].
Therefore, patients with Parkinson’s disease may very well have
deficient dopaminergic projections from VTA to M1. Considering
that these patients show reduced M1 plasticity [52] and deficits in
skill [8] and procedural learning [53], our findings provide a
potential mechanism for these deficits, that is the degeneration of
M1 dopaminergic signaling.
In conclusion, dopaminergic neurotransmission in primary
motor cortex plays a crucial role for motor skill learning and
synaptic plasticity in M1. These findings may open opportunities
for the development for novel therapies aiming to restore motor
function after brain injury or motor deficits in Parkinson’s disease.
Materials and Methods
All experiments were performed in adult male Long-Evans rats
(8–10 weeks, 250–350 g) raised in our animal facility. Animals
were housed individually in a 12/12-hr light/dark cycle (light on:
3am, off: 3pm). All procedures were conducted according to
national and international guidelines and were approved by the
Animal Care Committee of the State of Baden-Wu ¨rttemberg,
Germany. Chemicals and antibodies were purchased from
Sigma-Aldrich Chemie GmbH, Munich, Germany, unless noted
otherwise.
Behavior
Motor skill training. Training sessions were performed at
the beginning of the dark phase. Animals were food-restricted for
24 hr before the first pre-training session (see below). During
training animals were kept slightly over their initial weight
(332.1629.4 g) by providing 50 mg/kg of standard lab diet after
each training session. Water was given ad libitum.
Motor skill training was performed as previously described [27].
The training cage was a 15640 cm chamber (height 30 cm) with a
vertical window (1 cm wide, 5 cm high beginning 2 cm above
floor) in the front wall and a small light sensor in the rear wall
(7 cm above ground). Animals were first pre-trained for five days
learning to open the motorized sliding door that covered the front
window, by nose-poking the sensor in the rear. Opening the
window gave access to one food pellet (45 mg, Bio-serve,
Frenchtown, NJ, USA) located on a small horizontal board
outside of the cage. During pre-training pellets were retrieved by
tongue. Upon retrieval the pellet was automatically replaced by a
pellet dispenser. Pre-training was followed by 6–15-days of motor
skill training that was initiated by removing the board and placing
the pellet on a vertical post 1.5 cm away from the window. In this
position pellets were only retrievable by using the forelimb. The
first skill training session was to determine forelimb preference and
consisted of 50 door openings (=trials). Determination of
preference was necessary before surgical instrumentation of the
hemisphere contralateral to the preferred limb (see below). After
determining forelimb preference, the pedestal was shifted to one
side of the window to allow reaching with the preferred limb only,
contralateral to the hemisphere injected or instrumented for drug
injection. All subsequent sessions consisted of 100 trials. The
movement required to retrieve the pellet consisted of a forelimb
extension to the target, followed by pronation, paw opening,
grasping motion, forelimb retention combined with a supination to
bring the pellet to the mouth. Rats mainly improved target reach
and grasp elements to successfully retrieve the pellet during
training sessions. Each reaching trial was scored as ‘‘successful’’
(reach, grasp and retrieve) or ‘‘unsuccessful’’ (pellet pushed off
pedestal or dropped during retraction). The success rate was
defined as the ratio of the number of successful trials and the total
number of trials per session, i.e. 100. The latency between pellet
removal and subsequent door opening was used as an index
of motivation [27]. Daily training sessions consisted of 100 trials
(= door openings), involved 115.865.7 forelimb movements,
mean6SEM, automatically sensed by a sensor between cage wall
and pedestal) and lasted 24.860.5 min, mean6SEM.
Rotarod test. Four-limb motor function was examined to
avoid confounds of post-surgical discomfort and potential motor
deficits, and was assessed using an accelerated rotarod test (7 cm
diameter rod accelerating at 1 cm/s
2). Maximum velocity at the
time the rat fell off the rod, was an index of four-limb motor
function. Twenty runs were performed per session with a 15 sec
break between runs. Because rotarod performance initially
improves with practice [54], two baseline sessions were completed.
Surgical Procedures
All surgical procedures were performed under ketamine
(70 mg/kg, i.p.) and xylazine anesthesia (5 mg/kg, i.p.) with the
rats fixed in a stereotactic frame (Stoelting Co., Wood Dale, IL,
USA). Additional ketamine doses were administered if necessary.
Body temperature was controlled using a heating pad. Buprenor-
phin (0.01 mg/kg, i.p.) was given after surgery for pain relief. All
permanent implants were anchored onto the skull with two screws
(2 mm diameter) placed in the frontal and occipital skull. Bone
flaps were replaced and fixated using bone cement (FlowLine,
Heraus Kulzer, Dormagen, Germany).
Identification of the M1 forelimb area. The forelimb
representation was identified in each animal for optimal placement
of injection needles (6-OHDA and levodopa) and cannula
implantation (repeated antagonist injections). The brain was
exposed by craniotomy leaving the dura intact (coordinates with
respect to Bregma: 4 mm posterior to 5 mm anterior, 5 mm to
1 mm lateral). M1 somatotopy was mapped using a thin-film
microelectrode array (Multichannel Systems, Reutlingen,
Germany) as previously described [55]. The array was placed
onto the dura over the frontoparietal cortex. Biphasic stimuli (100
stimuli at 300 Hz, 1–5 mA constant current, 10 ms stimulus
interval) were applied to the 64 contacts of the electrode array in a
random sequence. Evoked limb twitches were visually identified.
The forelimb area was typically 2 to 3.5 mm lateral and 1.5 to
2.5 mm anterior to Bregma. All drug injections were performed in
a depth of 1 mm below the dura.
Histology
Positioning of guide cannulas for antagonist injections and
positioning of needles for single injections of 6-hydroxydopamine
(6-OHDA), and continuous infusion of levodopa with osmotic
minipumps was verified in each animal histologically by Nissl
staining. No animal had to be excluded because of misplacement
of needles or cannulas.
Elimination of dopamine terminals in M1
To test whether elimination of dopaminergic terminals in M1
affects motor skill learning, animals were injected with 6-OHDA
into M1 (0.5 mlo f6mg/ml 6-OHDA in 0.1% ascorbic acid, single
injection without guide cannula to minimize cortical injury). At the
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protect noradrenergic neurons (6-OHDA+D, n=6). These
animals were compared with sham-lesioned controls (0.5 mlo f
0.1% ascorbic acid in 0.9% NaCl, vehicle, n=11) and animals
with selective elimination of noradrenergic terminals using
intracortical 6-OHDA injections plus nomifensine (10 mg/kg,
i.p., 6-OHDA+N, n=6). All injections were performed after
training day 1 (50 trials) to determine forelimb preference and
baseline performance.
To test whether 6-OHDA+D effects were specific for motor skill
acquisition or were the result of a movement execution deficit, the
drug was injected during the plateau phase of the learning curve,
when no further skill learning occurred (injection on day 11,
n=10).
Levodopa substitution
In separate groups of rats, levodopa (5 mg/ml plus 1.25 mg/ml
benserazide, dissolved in 0.9% NaCl, containing 0.2 mg/ml
ascorbic acid) was administered into the M1 of rats with destroyed
M1 dopaminergic terminals to test whether levodopa can restore
the ability to acquire the motor skill. After the baseline training
session (50 trials), 6-OHDA+D lesions were performed. Following
a 3-day recovery period, rats were trained for 6 days. Then,
osmotic minipumps (0.25 ml/hr, 100 ml volume, model 1002,
Alzet, Cupertino, CA, USA) filled with levodopa or 0.9% NaCl
were implanted subcutaneously into the neck area. Minipumps
were connected by tubing tunnelled under the skin to a needle
implanted into the M1 forelimb representation. Animals recovered
for 3 days and were then retrained for 6 days. After the last
training session minipumps were explanted and recall training was
performed following 6 days of rest. 6-OHDA+D-lesioned and
levodopa-infused animals (6-OHDA+D+DA, n=7) were com-
pared with 6-OHDA+D-lesioned rats infused with vehicle (0.9%
NaCl containing 0.2 mg/ml ascorbic acid, 6-OHDA+D+vehicle,
n=7) and with sham-lesioned rats implanted with levodopa-
containing minipumps (vehicle+DA, n=10).
Immunochemical assessment dopamine terminals in M1
Western Blot analysis. The presence of dopaminergic
terminals in M1 was assessed using tyrosin hydroxylase Western
Blot analysis. One hemisphere was injected with 6-OHDA, the
contralateral hemisphere with vehicle (0.5 mlo f0 . 1 %a s c o r b i ca c i di n
0.9% NaCl). In addition, rats received desipramine (n=4, 20 mg/kg,
i.p.) to protect noradrenergic neurons while others received
nomifensine to protect dopaminergic neurons (n=4, 10 mg/kg,
i.p.). After three days rats were decapitated in ether anesthesia, brains
were quicklydissected over ice to isolate cortex, and visuallyinspected
to verify the injection site. The cortex was frozen on dry ice. Tissue
samples were sonicated in lysis buffer containing a protease inhibitor
cocktail, centrifuged, and the supernatant extracted for gel
electrophoresis. Equal amounts of lysates were subjected to SDS-
PAGEgels,whichwerethentransferredtonitrocellulosemembranes.
After blocking with 5% skim milk in tris-buffered saline, blots were
incubated with primary antibody, tyrosine hydroxylase (1:1000,
Chemicon, Hofheim, Germany). Antibody binding was detected
using a horseradish peroxidase secondary antibody (Amersham
Biosciences, GE Healthcare, Munich, Germany) and enhanced
chemiluminescence. Membranes were then stripped for 15 min at
25uC with Stripping Buffer (Pierce, Rockford, IL, USA) and
sequentially re-probed with polyclonal anti-b-actin antibody
(1:1000, Santa Cruz, Heidelberg, Germany) to ensure equal
protein loading across samples. Exposed films were scanned and
analyzed using band densitometry (Scion Image software, Frederick,
MD, USA).
For immunohistochemistry, three rats were treated with 6-
OHDA, vehicle and desipramine as described above. After three
days, the animals were perfused transcardially with 4% parafor-
maldehyde in 0.1 M phosphate buffer (PB, pH 7.4) after inducing
deep anesthesia (pentobarbital, 50 mg/kg i.p.). Brains were kept
for 24 hr in 4% PFA and then for 3–4 days in 30% sucrose before
rapid freezing in 2-methyl buthan. Coronal sections (40 mm) were
prepared using a cryostat (Leica Microsystems GmbH, Wetzlar,
Germany). Sections were rinsed twice in PBS, treated with 0.1%
Triton in PBS for 10 min and blocked for 30 min in 10% goat
serum. The sections were first incubated in a primary antibody
dilution (tyrosine hydroxylase, 1:100) in PBS, for 24 hr at 4uC,
then in secondary antibody dilution (cy3-conjugated) at room
temperature for 1 hr, and finally in Hoechst stain for 10 min.
Sections were mounted with Mowiol and inspected under a
fluorescent microscope (Axioplan II, Zeiss AG, Jena, Germany).
Dopamine antagonists in M1
To test the effects of DA receptor antagonist administration in
M1 on motor skill learning, rats received intracortical injections of
the D2-receptor antagonists raclopride (n=7, 10 mg/ml, S(2)-
Raclopride (+)-tartrate salt in 0.9% NaCl) or sulpiride (n=6,
20 mg/ml, (S)-(2)-sulpiride in 0.9% NaCl), or the D1-receptor
antagonist SCH 23390 (n=6, 600 mg/ml in 0.9% NaCl, Tocris
Biosciences, Avonmouth, UK), or vehicle solution (n=8, 0.9%
NaCl) 30 min before the beginning of the training sessions on day
2 and 3 of an 8-day training period. Rats were implanted with a
guide cannula (15 mm long, Unimed SA, Lausanne, Switzerland)
into the center of the left M1 forelimb representation. Cannulas
allowed drug application while the investigator restrained the rat
during injection in lieu of anesthesia. For injection a needle (34
Gauge, same length as guide cannula, Hamilton Bonaduz AG,
Switzerland) was inserted into the guide cannula after removing
the obturator. A volume of 0.5 ml was injected over 90 sec using a
microsyringe (5 ml, Hamilton Bonaduz AG, Switzerland) connect-
ed via tubing (10 cm, PE40 Plastics One, Roanoke, VA USA) to a
microinjection pump (Nano-injector, Stoelting Co., Wood Dale,
IL, USA).
To test whether raclopride effects were specific for motor skill
acquisition or were the result of a movement execution deficit, the
drug was injected during the plateau phase of the learning curve,
when no further skill learning occurred (injections before training
on days 11 and 12, n=5).
To test whether drug injections were specific to M1 and did not
spill into adjacent areas known to receive dopaminergic projec-
tions, raclopride (10 mg/ml, 0.5 ml) or vehicle (0.9% NaCl) were
injected into the dorsal striatum (implantation coordinates 3 mm
lateral, 0.5 mm anterior to bregma, 5 mm below dura, raclopride
n=10, vehicle n=10) or prefrontal cortex (coordinates: 1 mm
lateral, 5 mm anterior to bregma, 1 mm below dura, raclopride
n=6, vehicle n=6).
Dopamine antagonist effects on synaptic transmission
and plasticity
In vitro slice preparation. Deeply anesthetized untrained
rats (pentobarbital, 50 mg/kg) were decapitated, their brains
quickly removed and immersed in cold (5–7uC), oxygenated (95%
O2/5% CO2) artificial cerebrospinal fluid (ACSF) containing (in
mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 2 CaCl2,2 6
NaHCO3, 10 dextrose. Coronal slices (500 mm) including the M1
forelimb area (1.5–3.5 mm anterior to Bregma, 2–4 mm lateral) of
both hemispheres were prepared using a vibratome. Slices were
transferred to a temperature controlled (3460.5uC) interface
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2 ml/min. Slices were allowed to recover for at least one hour.
Stimulation and field potential recording. Concentric
bipolar stimulation electrodes were positioned symmetrically in
layer II/III of each hemisphere 2–2.5 mm lateral to the midline,
and recording electrodes placed 500 mm laterally. Extracellular
field potentials (FP) were evoked by 0.2 ms, 0.03 Hz stimulation
and recorded simultaneously in both hemispheres. Stimulation
intensity was adjusted until a response of 0.2 mV was recorded,
which was defined as the threshold intensity. Multiples of this
intensity were used for determination of input-output relationships
to assess the baseline synaptic strength.
Induction of LTP. The stimulus intensity eliciting 50% of the
maximum amplitude was used for all measurements before and
after LTP induction. Baseline amplitudes were recorded using
single stimuli applied every 30 sec. Following a 30-min stable
baseline period, LTP was induced by theta burst stimulation
(TBS), consisting of 10 trains of 5 Hz stimuli, each composed of 4
(200 msec) pulses at 100 Hz, repeated 5 times every 10 sec. During
TBS the stimulation intensity was doubled. TBS was applied
immediately after transient, local application of the GABAA
receptor antagonist bicuculline methiodide (3.5 mM) at the field
potential recording site until response amplitude increased to 150–
200% of baseline.
Statistical Analysis
Data analysis was performed using Statistica version 7.0
(StatSoft Inc., Tulsa OK, USA). Reaching performance was
quantified as the percentage of trials with successful retrievals per
session (=100 trials). General linear repeated measures models
were used to test for effects of training day on reaching performance
including group, baseline performance, and the interaction of group6time
(session) as independent variables. Whether data met the sphericity
condition was tested using Mauchly’s criterion and if not met,
Geisser and Greenhouse correction was applied. Post hoc tests
were performed using Bonferroni correction for multiple compar-
isons or Dunett’s test for comparison with a control group. Two-
tailed probability less or equal to 5% was considered significant.
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